Risk of Parkinson's disease following severe constipation: A nationwide population-based cohort study

Parkinsonism and Related Disorders

Volumn 20, Issue 12, 2014, Pages 1371-1375

  Lin, Chin Hsien ^a   Lin, Jou Wei ^a,b   Liu, Ying Chun ^c   Chang, Chia Hsuin ^b,c   Wu, Ruey Meei ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Constipation; Non motor symptoms; Parkinson's disease; Population study; Pre motor symptoms

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONSTIPATION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR;

EID: 84916220447     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.09.026     Document Type: Article

References (23)

1. Chaudhuri K.R., Schapira A.H. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009, 8:464-474.
2. Hawkes C.H., Del Tredici K., Braak H. Atimeline for Parkinson's disease. Parkinsonism Relat Disord 2010, 16:79-84.
3. Abbott R.D., Petrovitch H., White L.R., Masaki K.H., Tanner C.M., Curb J.D., et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001, 57:456-462.
4. Savica R., Carlin J.M., Grossardt B.R., Bower J.H., Ahlskog J.E., Maraganore D.M., et al. Medical records documentation of constipation preceding Parkinson disease: a case-control study. Neurology 2009, 73:1752-1758.
5. Gao X., Chen H., Schwarzschild M.A., Ascherio A. Aprospective study of bowel movement frequency and risk of Parkinson's disease. Am J Epidemiol 2011, 174:546-551.
6. Braak H., Del Tredici K., Rüb U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211.
7. Petrovitch H., Abbott R.D., Ross G.W., Nelson J., Masaki K.H., Tanner C.M., et al. Bowel movement frequency in late-life and substantia nigra neuron density at death. Mov Disord 2009, 24:371-376.
8. Lee Y.C., Lin C.H., Wu R.M., Lin M.S., Lin J.W., Chang C.H., et al. Discontinuation of statin therapy associates with Parkinson disease: a population-based study. Neurology 2013, 81:410-416.
9. Lin C.H., Wu R.M., Chang H.Y., Chiang Y.T., Lin H.H. Preceding pain symptoms and Parkinson's disease: a nationwide population-based cohort study. Eur J Neurol 2013, 20:1398-1404.
10. Qiu C., Hu G., Kivipelto M., Laatikainen T., Antikainen R., Fratiglioni L., et al. Association of blood pressure and hypertension with the risk of Parkinson disease: the National FINRISK Study. Hypertension 2011, 57:1094-1100.
11. Sun Y., Chang Y.H., Chen H.F., Su Y.H., Su H.F., Li C.Y. Risk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications. Diabetes Care 2012, 35:1047-1049.
12. Cereda E., Barichella M., Pedrolli C., Klersy C., Cassani E., Caccialanza R., et al. Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis. Diabetes Care 2011, 34:2614-2623.
13. Wahner A.D.1, Bronstein J.M., Bordelon Y.M., Ritz B. Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease. Neurology 2007, 69:1836-1842.
14. Becker C., Jick S.S., Meier C.R. Use of antihypertensives and the risk of Parkinson disease. Neurology 2008, 70:1438-1444.
15. Lee Y.C., Lin C.H., Wu R.M., Lin J.W., Chang C.H., Lai M.S. Antihypertensive agents and risk of Parkinson's disease: a nationwide cohort study. PLoS One 2014, 9:e98961. 10.1371/journal.pone.0098961.
16. Abbott R.D., Ross G.W., Petrovitch H., Tanner C.M., Davis D.G., Masaki K.H., et al. Bowel movement frequency in late-life and incidental Lewy bodies. Mov Disord 2007, 22:1581-1586.
17. Abbott R.D., Ross G.W., White L.R., Sanderson W.T., Burchfiel C.M., Kashon M., et al. Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging Study. JNeurol 2003, 250(Suppl.3):III30-III39.
18. Ueki A., Otsuka M. Life style risks of Parkinson's disease: association between decreased water intake and constipation. JNeurol 2004, 251:vII18-23.
19. Minguez-Castellanos A., Chamorro C.E., Escamilla-Sevilla F., Ortega-Moreno A., Rebollo A.C., Gomez-Rio M., et al. Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: a cohort study. Neurology 2007, 68:2012-2018.
20. Fearnley J.M., Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991, 114:2283-2301.
21. Morrish P.K., Rakshi J.S., Bailey D.L., Sawle G.V., Brooks D.J. Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET. JNeurol Neurosurg Psychiatr 1998, 64:314-319.
22. Hawkes C.H., Del Tredici K., Braak H. Parkinson's disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 2007, 33:599-614.
23. Louis C.S.Tan Epidemiology of Parkinson's disease. Neurol Asia 2013, 8:231-238.